{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:28:07Z","timestamp":1794983287870,"version":"4.9.1"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170804"],"award-info":[{"award-number":["82170804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022YFC3602300"],"award-info":[{"award-number":["2022YFC3602300"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>HMGB1, a nucleoprotein, is expressed in almost all eukaryotic cells. During cell activation and cell death, HMGB1 can function as an alarm protein (alarmin) or damage-associated molecular pattern (DAMP) and mediate early inflammatory and immune response when it is translocated to the extracellular space. The binding of extracellular HMGB1 to Toll-like receptors (TLRs), such as TLR2 and TLR4 transforms HMGB1 into a pro-inflammatory cytokine, contributing to the occurrence and development of autoimmune diseases. TLRs, which are members of a family of pattern recognition receptors, can bind to endogenous DAMPs and activate the innate immune response. Additionally, TLRs are key signaling molecules mediating the immune response and play a critical role in the host defense against pathogens and the maintenance of immune balance. HMGB1 and TLRs are reported to be upregulated in several autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes mellitus, and autoimmune thyroid disease. The expression levels of HMGB1 and some TLRs are upregulated in tissues of patients with autoimmune diseases and animal models of autoimmune diseases. The suppression of HMGB1 and TLRs inhibits the progression of inflammation in animal models. Thus, HMGB1 and TLRs are indispensable biomarkers and important therapeutic targets for autoimmune diseases. This review provides comprehensive strategies for treating or preventing autoimmune diseases discovered in recent years.<\/jats:p>","DOI":"10.1186\/s10020-023-00717-3","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T17:01:52Z","timestamp":1693846912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases"],"prefix":"10.1186","volume":"29","author":[{"given":"Wenxuan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-8330","authenticated-orcid":false,"given":"Xiaoguang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"717_CR1","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.22848","volume":"56","author":"S Abdollahi-Roodsaz","year":"2007","unstructured":"Abdollahi-Roodsaz S, Joosten LAB, Roelofs MF, Radstake TRDJ, Matera G, Popa C, et al. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 2007;56:2957\u201367.","journal-title":"Arthritis Rheum"},{"key":"717_CR2","volume":"2014","author":"AM Abu El-Asrar","year":"2014","unstructured":"Abu El-Asrar AM, Siddiquei MM, Nawaz MI, Geboes K, Mohammad G. The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes. Mediat Inflamm. 2014;2014: 746415.","journal-title":"Mediat Inflamm"},{"key":"717_CR3","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/art.21488","volume":"52","author":"E Af Klint","year":"2005","unstructured":"Af Klint E, Grundtman C, Engstr\u00f6m M, Catrina AI, Makrygiannakis D, Klareskog L, et al. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis Rheum. 2005;52:3880\u20139.","journal-title":"Arthritis Rheum"},{"key":"717_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/cyto.2002.0890","volume":"18","author":"D Agnello","year":"2002","unstructured":"Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine. 2002;18:231\u20136.","journal-title":"Cytokine"},{"key":"717_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565\u201370.","journal-title":"J Exp Med"},{"key":"717_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","volume":"22","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 2018;22:263\u201377.","journal-title":"Expert Opin Ther Targets"},{"key":"717_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar2488","volume":"10","author":"SP Ardoin","year":"2008","unstructured":"Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res Ther. 2008;10:218.","journal-title":"Arthritis Res Ther"},{"key":"717_CR8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/0961203307081895","volume":"16","author":"V Barkauskaite","year":"2007","unstructured":"Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus. 2007;16:794\u2013802.","journal-title":"Lupus"},{"key":"717_CR9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","volume":"430","author":"B Beutler","year":"2004","unstructured":"Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004;430:257\u201363.","journal-title":"Nature"},{"key":"717_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05144.x","author":"ME Bianchi","year":"1992","unstructured":"Bianchi ME, Falciola L, Ferrari S, Lilley DM. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 1992. https:\/\/doi.org\/10.1002\/j.1460-2075.1992.tb05144.x.","journal-title":"EMBO J"},{"key":"717_CR11","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","volume":"22","author":"T Bonaldi","year":"2003","unstructured":"Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003;22:5551\u201360.","journal-title":"EMBO J"},{"key":"717_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.str.2011.02.004","volume":"19","author":"I Botos","year":"2011","unstructured":"Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure. 2011;19:447\u201359.","journal-title":"Structure"},{"key":"717_CR13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0968-0004(00)01777-1","volume":"26","author":"M Bustin","year":"2001","unstructured":"Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci. 2001;26:152\u20133.","journal-title":"Trends Biochem Sci"},{"key":"717_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0006-291X(81)91833-7","volume":"101","author":"M Bustin","year":"1981","unstructured":"Bustin M, Neihart NK, Fagan JB. mRNA of chromosomal proteins HMG-1 and HMG-2 are polyadenylated. Biochem Biophys Res Commun. 1981;101:893\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"717_CR15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2249.1990.tb05482.x","volume":"82","author":"T Cavallo","year":"1990","unstructured":"Cavallo T, Granholm NA. Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL\/lpr mice. Clin Exp Immunol. 1990a;82:515\u201321.","journal-title":"Clin Exp Immunol"},{"key":"717_CR16","first-page":"971","volume":"137","author":"T Cavallo","year":"1990","unstructured":"Cavallo T, Granholm NA. Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB\/W mice. Am J Pathol. 1990b;137:971\u20138.","journal-title":"Am J Pathol"},{"key":"717_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4049\/jimmunol.1102977","volume":"189","author":"ND Chamberlain","year":"2012","unstructured":"Chamberlain ND, Vila OM, Volin MV, Volkov S, Pope RM, Swedler W, et al. TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-\u03b1 levels. J Immunol. 2012;189:475\u201383.","journal-title":"J Immunol"},{"key":"717_CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/annrheumdis-2011-201203","volume":"72","author":"ND Chamberlain","year":"2013","unstructured":"Chamberlain ND, Kim S, Vila OM, Volin MV, Volkov S, Pope RM, et al. Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNF\u03b1 in monocytes. Ann Rheum Dis. 2013;72:418\u201326.","journal-title":"Ann Rheum Dis"},{"key":"717_CR19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/ket134","volume":"52","author":"Y Chen","year":"2013","unstructured":"Chen Y, Sun W, Gao R, Su Y, Umehara H, Dong L, et al. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology. 2013;52:1739\u201347.","journal-title":"Rheumatology"},{"key":"717_CR20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen R, Kang R, Tang D. The mechanism of HMGB1 secretion and release. Exp Mol Med. 2022;54:91\u2013102.","journal-title":"Exp Mol Med"},{"key":"717_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/thy.2014.0135","volume":"25","author":"WK Cho","year":"2015","unstructured":"Cho WK, Jang J-P, Choi E-J, Jeon YJ, Jung IA, Kim S-H, et al. Association of Toll-like receptor 10 polymorphisms with autoimmune thyroid disease in Korean children. Thyroid. 2015;25:250\u20135.","journal-title":"Thyroid"},{"key":"717_CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25:417\u201328.","journal-title":"Immunity"},{"key":"717_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4781(00)00289-X","volume":"1518","author":"T Chuang","year":"2001","unstructured":"Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta. 2001;1518:157\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"717_CR24","volume":"118","author":"FIL Clanchy","year":"2021","unstructured":"Clanchy FIL, Borghese F, Bystrom J, Balog A, Penn H, Hull DN, et al. TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis. J Autoimmun. 2021;118: 102597.","journal-title":"J Autoimmun"},{"key":"717_CR25","doi-asserted-by":"crossref","first-page":"E810","DOI":"10.1152\/ajpendo.00566.2012","volume":"304","author":"P Dandona","year":"2013","unstructured":"Dandona P, Ghanim H, Green K, Sia CL, Abuaysheh S, Kuhadiya N, et al. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Am J Physiol Endocrinol Metab. 2013;304:E810-818.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"717_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039836","volume":"7","author":"F Delucchi","year":"2012","unstructured":"Delucchi F, Berni R, Frati C, Cavalli S, Graiani G, Sala R, et al. Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats. PLoS ONE. 2012;7: e39836.","journal-title":"PLoS ONE"},{"key":"717_CR27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2007-2185","volume":"93","author":"S Devaraj","year":"2008","unstructured":"Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008;93:578\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"717_CR28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.biocel.2009.10.009","volume":"42","author":"SK Drexler","year":"2010","unstructured":"Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010;42:506\u201318.","journal-title":"Int J Biochem Cell Biol"},{"key":"717_CR29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2005.04.009","volume":"26","author":"IE Dumitriu","year":"2005","unstructured":"Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol. 2005;26:381\u20137.","journal-title":"Trends Immunol"},{"key":"717_CR30","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102496","volume":"19","author":"KA Dvornikova","year":"2020","unstructured":"Dvornikova KA, Bystrova EY, Platonova ON, Churilov LP. Polymorphism of toll-like receptor genes and autoimmune endocrine diseases. Autoimmun Rev. 2020;19: 102496.","journal-title":"Autoimmun Rev"},{"key":"717_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.autrev.2016.12.003","volume":"16","author":"HA Elshabrawy","year":"2017","unstructured":"Elshabrawy HA, Essani AE, Szekanecz Z, Fox DA, Shahrara S. TLRs, future potential therapeutic targets for RA. Autoimmun Rev. 2017;16:103\u201313.","journal-title":"Autoimmun Rev"},{"key":"717_CR32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00296-010-1472-8","volume":"31","author":"EO Etem","year":"2011","unstructured":"Etem EO, Elyas H, Ozgocmen S, Y\u0131ld\u0131r\u0131m A, Godekmerdan A. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int. 2011;31:1369\u201374.","journal-title":"Rheumatol Int"},{"key":"717_CR33","doi-asserted-by":"crossref","first-page":"28803","DOI":"10.1016\/S0021-9258(19)61977-0","volume":"269","author":"S Ferrari","year":"1994","unstructured":"Ferrari S, Ronfani L, Calogero S, Bianchi ME. The mouse gene coding for high mobility group 1 protein (HMG1). J Biol Chem. 1994;269:28803\u20138.","journal-title":"J Biol Chem"},{"key":"717_CR34","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1182\/blood-2002-05-1300","volume":"101","author":"C Fiuza","year":"2003","unstructured":"Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101:2652\u201360.","journal-title":"Blood"},{"key":"717_CR35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2017.03.048","volume":"803","author":"S Gao","year":"2017","unstructured":"Gao S, Gong Y, Ji J, Yuan L, Han L, Guo Y, et al. A new benzenediamine derivative modulates Toll-like receptors-induced myeloid dendritic cells activation and ameliorates lupus-like syndrome in MRLlpr\/lpr mice. Eur J Pharmacol. 2017;803:94\u2013102.","journal-title":"Eur J Pharmacol"},{"key":"717_CR36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","volume":"3","author":"S Gardella","year":"2002","unstructured":"Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002;3:995\u20131001.","journal-title":"EMBO Rep"},{"key":"717_CR37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri3713","volume":"14","author":"NJ Gay","year":"2014","unstructured":"Gay NJ, Symmons MF, Gangloff M, Bryant CE. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014;14:546\u201358.","journal-title":"Nat Rev Immunol"},{"key":"717_CR38","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/cells10051044","volume":"10","author":"Y Ge","year":"2021","unstructured":"Ge Y, Huang M, Yao Y-M. The effect and regulatory mechanism of high mobility group box-1 protein on immune cells in inflammatory diseases. Cells. 2021;10:1044.","journal-title":"Cells"},{"key":"717_CR39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1432-1033.1973.tb03188.x","volume":"40","author":"GH Goodwin","year":"1973","unstructured":"Goodwin GH, Johns EW. Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids. Eur J Biochem. 1973;40:215\u20139.","journal-title":"Eur J Biochem"},{"key":"717_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1432-1033.1973.tb03026.x","volume":"38","author":"GH Goodwin","year":"1973","unstructured":"Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem. 1973;38:14\u20139.","journal-title":"Eur J Biochem"},{"key":"717_CR41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0005-2787(78)90081-3","volume":"519","author":"GH Goodwin","year":"1978","unstructured":"Goodwin GH, Johns EW. Are the high mobility group non-histone chromosomal proteins associated with \u2018active\u2019 chromatin? Biochimica Et Biophysica Acta Nucleic Acids and Protein Synthesis. 1978;519:279\u201384.","journal-title":"Biochimica Et Biophysica Acta Nucleic Acids and Protein Synthesis"},{"key":"717_CR42","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0901888","volume":"184","author":"Y Guan","year":"2010","unstructured":"Guan Y, Ranoa DRE, Jiang S, Mutha SK, Li X, Baudry J, et al. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J Immunol. 2010;184:5094\u2013103.","journal-title":"J Immunol"},{"key":"717_CR43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fendo.2018.00630","volume":"9","author":"Y Guo","year":"2018","unstructured":"Guo Y, Xiao Z, Wang Y, Yao W, Liao S, Yu B, et al. Sodium butyrate ameliorates streptozotocin-induced type 1 diabetes in mice by inhibiting the hmgb1 expression. Front Endocrinol (lausanne). 2018;9:630.","journal-title":"Front Endocrinol (lausanne)"},{"key":"717_CR44","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.2147\/DDDT.S325814","volume":"15","author":"Q Guo","year":"2021","unstructured":"Guo Q, Qu H, Zhang H, Zhong X. Prunella vulgaris L. attenuates experimental autoimmune thyroiditis by inhibiting HMGB1\/TLR9 signaling. Drug Des Devel Ther. 2021;15:4559\u201374.","journal-title":"Drug Des Devel Ther"},{"key":"717_CR45","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/art.23729","volume":"58","author":"T Hamada","year":"2008","unstructured":"Hamada T, Torikai M, Kuwazuru A, Tanaka M, Horai N, Fukuda T, et al. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthr Rheum. 2008;58:2675\u201385.","journal-title":"Arthr Rheum"},{"key":"717_CR46","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2337\/db07-1499","volume":"57","author":"J Han","year":"2008","unstructured":"Han J, Zhong J, Wei W, Wang Y, Huang Y, Yang P, et al. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes. 2008;57:2118\u201327.","journal-title":"Diabetes"},{"key":"717_CR47","doi-asserted-by":"crossref","first-page":"16596","DOI":"10.1021\/bi00051a007","volume":"34","author":"CH Hardman","year":"1995","unstructured":"Hardman CH, Broadhurst RW, Raine AR, Grasser KD, Thomas JO, Laue ED. Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry. 1995;34:16596\u2013607.","journal-title":"Biochemistry"},{"key":"717_CR48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/me.2004-0100","volume":"19","author":"N Harii","year":"2005","unstructured":"Harii N, Lewis CJ, Vasko V, McCall K, Benavides-Peralta U, Sun X, et al. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto\u2019s autoimmune thyroiditis. Mol Endocrinol. 2005;19:1231\u201350.","journal-title":"Mol Endocrinol"},{"key":"717_CR49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-3083.2012.02759.x","volume":"76","author":"Z He","year":"2012","unstructured":"He Z, Shotorbani SS, Jiao Z, Su Z, Tong J, Liu Y, et al. HMGB1 promotes the differentiation of Th17 via up-regulating TLR2 and IL-23 of CD14+ monocytes from patients with rheumatoid arthritis. Scand J Immunol. 2012;76:483\u201390.","journal-title":"Scand J Immunol"},{"key":"717_CR50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585282","volume":"11","author":"AB Hegewald","year":"2020","unstructured":"Hegewald AB, Breitwieser K, Ottinger SM, Mobarrez F, Korotkova M, Rethi B, et al. Extracellular miR-574-5p induces osteoclast differentiation via TLR 7\/8 in rheumatoid arthritis. Front Immunol. 2020;11: 585282.","journal-title":"Front Immunol"},{"key":"717_CR51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/cvr\/cvt275","volume":"101","author":"C Herzog","year":"2014","unstructured":"Herzog C, Lorenz A, Gillmann H-J, Chowdhury A, Larmann J, Harendza T, et al. Thrombomodulin\u2019s lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling. Cardiovasc Res. 2014;101:400\u201310.","journal-title":"Cardiovasc Res"},{"key":"717_CR52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","volume":"3","author":"MA Hofmann","year":"2002","unstructured":"Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002;3:123\u201335.","journal-title":"Genes Immun"},{"key":"717_CR53","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1016\/j.yexcr.2006.07.020","volume":"312","author":"G Hoppe","year":"2006","unstructured":"Hoppe G, Talcott KE, Bhattacharya SK, Crabb JW, Sears JE. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res. 2006;312:3526\u201338.","journal-title":"Exp Cell Res"},{"key":"717_CR54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/annrheumdis-2012-202444","volume":"73","author":"F Hu","year":"2014","unstructured":"Hu F, Mu R, Zhu J, Shi L, Li Y, Liu X, et al. Hypoxia and hypoxia-inducible factor-1\u03b1 provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis. 2014;73:928\u201336.","journal-title":"Ann Rheum Dis"},{"key":"717_CR55","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.22707","volume":"56","author":"Q Huang","year":"2007","unstructured":"Huang Q, Ma Y, Adebayo A, Pope RM. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthr Rheum. 2007;56:2192\u2013201.","journal-title":"Arthr Rheum"},{"key":"717_CR56","first-page":"4805","volume":"62","author":"HJ Huttunen","year":"2002","unstructured":"Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 2002;62:4805\u201311.","journal-title":"Cancer Res"},{"key":"717_CR57","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.20219","volume":"50","author":"M Iwahashi","year":"2004","unstructured":"Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthr Rheum. 2004;50:1457\u201367.","journal-title":"Arthr Rheum"},{"key":"717_CR58","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987\u201395.","journal-title":"Nat Immunol"},{"key":"717_CR59","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.1400098","volume":"192","author":"SW Jackson","year":"2014","unstructured":"Jackson SW, Scharping NE, Kolhatkar NS, Khim S, Schwartz MA, Li Q-Z, et al. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol. 2014;192:4525\u201332.","journal-title":"J Immunol"},{"key":"717_CR60","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.18632\/aging.102052","volume":"11","author":"J Ji","year":"2019","unstructured":"Ji J, Fu T, Dong C, Zhu W, Yang J, Kong X, et al. Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells. Aging. 2019;11:4338\u201353.","journal-title":"Aging"},{"key":"717_CR61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2014.07.003","volume":"28","author":"I Jialal","year":"2014","unstructured":"Jialal I, Major AM, Devaraj S. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complicat. 2014;28:755\u201361.","journal-title":"J Diabetes Complicat"},{"key":"717_CR62","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.2007.074484","volume":"67","author":"W Jiang","year":"2008","unstructured":"Jiang W, Pisetsky DS. Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis. 2008;67:727\u20138.","journal-title":"Ann Rheum Dis"},{"key":"717_CR63","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar1864","volume":"8","author":"SL Jongbloed","year":"2006","unstructured":"Jongbloed SL, Lebre MC, Fraser AR, Gracie JA, Sturrock RD, Tak PP, et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthr Res Ther. 2006;8:R15.","journal-title":"Arthr Res Ther"},{"key":"717_CR64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2006.12.006","volume":"109","author":"YO Jung","year":"2007","unstructured":"Jung YO, Cho M-L, Kang C-M, Jhun J-Y, Park J-S, Oh H-J, et al. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol Lett. 2007;109:21\u20137.","journal-title":"Immunol Lett"},{"key":"717_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Mol Aspects Med. 2014;40:1\u2013116.","journal-title":"Mol Aspects Med"},{"key":"717_CR66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.","journal-title":"Front Immunol"},{"key":"717_CR67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imlet.2007.03.004","volume":"110","author":"K-W Kim","year":"2007","unstructured":"Kim K-W, Cho M-L, Lee S-H, Oh H-J, Kang C-M, Ju JH, et al. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett. 2007;110:54\u201364.","journal-title":"Immunol Lett"},{"key":"717_CR68","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/art.37992","volume":"65","author":"S-J Kim","year":"2013","unstructured":"Kim S-J, Chen Z, Chamberlain ND, Volin MV, Swedler W, Volkov S, et al. Angiogenesis in rheumatoid arthritis is fostered directly by toll-like receptor 5 ligation and indirectly through interleukin-17 induction. Arthr Rheum. 2013;65:2024\u201336.","journal-title":"Arthr Rheum"},{"key":"717_CR69","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.1302998","volume":"193","author":"S-J Kim","year":"2014","unstructured":"Kim S-J, Chen Z, Chamberlain ND, Essani AB, Volin MV, Amin MA, et al. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis. J Immunol. 2014;193:3902\u201313.","journal-title":"J Immunol"},{"key":"717_CR70","doi-asserted-by":"crossref","first-page":"20169","DOI":"10.1038\/s41598-021-99625-x","volume":"11","author":"W Kim","year":"2021","unstructured":"Kim W, Kim TH, Oh SJ, Kim HJ, Kim JH, Kim H-A, et al. Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-\u03b1 inhibitors and development of machine learning models. Sci Rep. 2021;11:20169.","journal-title":"Sci Rep"},{"key":"717_CR71","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1038\/srep07290","volume":"4","author":"J Kimura","year":"2014","unstructured":"Kimura J, Ichii O, Miyazono K, Nakamura T, Horino T, Otsuka-Kanazawa S, et al. Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep. 2014;4:7290.","journal-title":"Sci Rep"},{"key":"717_CR72","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/art.10540","volume":"46","author":"R Kokkola","year":"2002","unstructured":"Kokkola R, Sundberg E, Ulfgren A-K, Palmblad K, Li J, Wang H, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthr Rheum. 2002;46:2598\u2013603.","journal-title":"Arthr Rheum"},{"key":"717_CR73","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2249.2008.03646.x","volume":"152","author":"A Komatsuda","year":"2008","unstructured":"Komatsuda A, Wakui H, Iwamoto K, Ozawa M, Togashi M, Masai R, et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol. 2008;152:482\u20137.","journal-title":"Clin Exp Immunol"},{"key":"717_CR74","doi-asserted-by":"crossref","first-page":"12061","DOI":"10.1073\/pnas.0905441106","volume":"106","author":"DH Kono","year":"2009","unstructured":"Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, et al. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U S A. 2009;106:12061\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"717_CR75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/glia.22581","volume":"62","author":"MD Laird","year":"2014","unstructured":"Laird MD, Shields JS, Sukumari-Ramesh S, Kimbler DE, Fessler RD, Shakir B, et al. High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia. 2014;62:26\u201338.","journal-title":"Glia"},{"key":"717_CR76","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.4049\/jimmunol.0803219","volume":"183","author":"A Lartigue","year":"2009","unstructured":"Lartigue A, Colliou N, Calbo S, Fran\u00e7ois A, Jacquot S, Arnoult C, et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol. 2009;183:6207\u201316.","journal-title":"J Immunol"},{"key":"717_CR77","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1084\/jem.20080462","volume":"205","author":"PY Lee","year":"2008","unstructured":"Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med. 2008;205:2995\u20133006.","journal-title":"J Exp Med"},{"key":"717_CR78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/imm.12196","volume":"141","author":"S-Y Lee","year":"2014","unstructured":"Lee S-Y, Yoon B-Y, Kim J-I, Heo Y-M, Woo Y-J, Park S-H, et al. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Immunology. 2014;141:353\u201361.","journal-title":"Immunology"},{"key":"717_CR79","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun. 2015;64:82\u201390.","journal-title":"J Autoimmun"},{"key":"717_CR80","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0961203315622823","volume":"25","author":"YH Lee","year":"2016","unstructured":"Lee YH, Choi SJ, Ji JD, Song GG. Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lupus. 2016;25:593\u2013601.","journal-title":"Lupus"},{"key":"717_CR81","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41590-022-01310-2","volume":"23","author":"C Leibler","year":"2022","unstructured":"Leibler C, John S, Elsner RA, Thomas KB, Smita S, Joachim S, et al. Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus. Nat Immunol. 2022;23:1457\u201369.","journal-title":"Nat Immunol"},{"key":"717_CR82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03402105","volume":"9","author":"J Li","year":"2003","unstructured":"Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med. 2003;9:37\u201345.","journal-title":"Mol Med"},{"key":"717_CR83","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3899\/jrheum.090663","volume":"37","author":"J Li","year":"2010","unstructured":"Li J, Xie H, Wen T, Liu H, Zhu W, Chen X. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol. 2010;37:766\u201375.","journal-title":"J Rheumatol"},{"key":"717_CR84","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.25011\/cim.v34i5.15673","volume":"34","author":"Z-C Li","year":"2011","unstructured":"Li Z-C, Cheng G-Q, Hu K-Z, Li M-Q, Zang W-P, Dong Y-Q, et al. Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis. Clin Invest Med. 2011;34:E298.","journal-title":"Clin Invest Med"},{"key":"717_CR85","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/thy.2016.0432","volume":"27","author":"C Li","year":"2017","unstructured":"Li C, Peng S, Liu X, Han C, Wang X, Jin T, et al. Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling. Thyroid. 2017;27:722\u201331.","journal-title":"Thyroid"},{"key":"717_CR86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2020.00229","volume":"11","author":"W Li","year":"2020","unstructured":"Li W, Deng M, Loughran PA, Yang M, Lin M, Yang C, et al. LPS induces active HMGB1 release from hepatocytes into exosomes through the coordinated activities of TLR4 and caspase-11\/GSDMD signaling. Front Immunol. 2020;11:229.","journal-title":"Front Immunol"},{"key":"717_CR87","volume":"5","author":"K-H Lim","year":"2013","unstructured":"Lim K-H, Staudt LM. Toll-like receptor signaling. Cold Spring Harb Perspect Biol. 2013;5: a011247.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"717_CR88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","volume":"23","author":"M Lin","year":"2012","unstructured":"Lin M, Yiu WH, Wu HJ, Chan LYY, Leung JCK, Au WS, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 2012;23:86\u2013102.","journal-title":"J Am Soc Nephrol"},{"key":"717_CR89","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.4049\/jimmunol.177.10.6880","volume":"177","author":"B Liu","year":"2006","unstructured":"Liu B, Yang Y, Dai J, Medzhitov R, Freudenberg MA, Zhang PL, et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol. 2006;177:6880\u20138.","journal-title":"J Immunol"},{"key":"717_CR90","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1159\/000517185","volume":"182","author":"X Lu","year":"2021","unstructured":"Lu X, Gong S, Wang X, Hu N, Pu D, Zhang J, et al. Celastrol exerts cardioprotective effect in rheumatoid arthritis by inhibiting TLR2\/HMGB1 signaling pathway-mediated autophagy. Int Arch Allergy Immunol. 2021;182:1245\u201354.","journal-title":"Int Arch Allergy Immunol"},{"key":"717_CR91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics13020142","volume":"13","author":"M Luchner","year":"2021","unstructured":"Luchner M, Reinke S, Milicic A. TLR agonists as vaccine adjuvants targeting cancer and infectious diseases. Pharmaceutics. 2021;13:142.","journal-title":"Pharmaceutics"},{"key":"717_CR92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00296-010-1636-6","volume":"32","author":"C Ma","year":"2012","unstructured":"Ma C, Jiao Y, Zhang J, Yang Q, Zhang Z, Shen Y, et al. Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-\u03b1 and TNF-\u03b1 in systemic lupus erythematosus. Rheumatol Int. 2012;32:395\u2013402.","journal-title":"Rheumatol Int"},{"key":"717_CR93","volume":"9","author":"J Ma","year":"2014","unstructured":"Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS ONE. 2014;9: e97985.","journal-title":"PLoS ONE"},{"key":"717_CR94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2119\/molmed.2013.00164","volume":"20","author":"M Magna","year":"2014","unstructured":"Magna M, Pisetsky DS. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med. 2014;20:138\u201346.","journal-title":"Mol Med"},{"key":"717_CR95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/JLB.3MIR1218-483RR","volume":"106","author":"L Marongiu","year":"2019","unstructured":"Marongiu L, Gornati L, Artuso I, Zanoni I, Granucci F. Below the surface: the inner lives of TLR4 and TLR9. J Leukoc Biol. 2019;106:147\u201360.","journal-title":"J Leukoc Biol"},{"key":"717_CR96","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar3034","volume":"12","author":"L Meng","year":"2010","unstructured":"Meng L, Zhu W, Jiang C, He X, Hou W, Zheng F, et al. Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthr Res Ther. 2010;12:R103.","journal-title":"Arthr Res Ther"},{"key":"717_CR97","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/cen.12872","volume":"84","author":"F Mobarrez","year":"2016","unstructured":"Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A, Pisetsky DS, et al. The expression of microvesicles in the blood of patients with Graves\u2019 disease and its relationship to treatment. Clin Endocrinol. 2016;84:729\u201335.","journal-title":"Clin Endocrinol"},{"key":"717_CR98","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2005.06.009","volume":"26","author":"PN Moynagh","year":"2005","unstructured":"Moynagh PN. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005;26:469\u201376.","journal-title":"Trends Immunol"},{"key":"717_CR99","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.0902592","volume":"184","author":"KM Nickerson","year":"2010","unstructured":"Nickerson KM, Christensen SR, Shupe J, Kashgarian M, Kim D, Elkon K, et al. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol. 2010;184:1840\u20138.","journal-title":"J Immunol"},{"key":"717_CR100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00296-012-2578-y","volume":"33","author":"P Oktayoglu","year":"2013","unstructured":"Oktayoglu P, Em S, Tahtasiz M, Bozkurt M, Ucar D, Yazmalar L, et al. Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life. Rheumatol Int. 2013;33:1327\u201331.","journal-title":"Rheumatol Int"},{"key":"717_CR101","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biocel.2009.10.010","volume":"42","author":"C Ospelt","year":"2010","unstructured":"Ospelt C, Gay S. TLRs and chronic inflammation. Int J Biochem Cell Biol. 2010;42:495\u2013505.","journal-title":"Int J Biochem Cell Biol"},{"key":"717_CR102","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1002\/art.24140","volume":"58","author":"C Ospelt","year":"2008","unstructured":"Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008;58:3684\u201392.","journal-title":"Arthritis Rheum"},{"key":"717_CR103","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/art.27590","volume":"62","author":"T Ostberg","year":"2010","unstructured":"Ostberg T, Kawane K, Nagata S, Yang H, Chavan S, Klevenvall L, et al. Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model. Arthr Rheum. 2010;62:2963\u201372.","journal-title":"Arthr Rheum"},{"key":"717_CR104","volume":"11","author":"AM Owen","year":"2020","unstructured":"Owen AM, Fults JB, Patil NK, Hernandez A, Bohannon JK. TLR agonists as mediators of trained immunity: mechanistic insight and immunotherapeutic potential to combat infection. Front Immunol. 2020;11: 622614.","journal-title":"Front Immunol"},{"key":"717_CR105","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar2155","volume":"9","author":"K Palmblad","year":"2007","unstructured":"Palmblad K, Sundberg E, Diez M, S\u00f6derling R, Aveberger A-C, Andersson U, et al. Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. Arthr Res Ther. 2007;9:R35.","journal-title":"Arthr Res Ther"},{"key":"717_CR106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cei.13566","volume":"204","author":"A Paradowska-Gorycka","year":"2021","unstructured":"Paradowska-Gorycka A, Wajda A, Stypinska B, Walczuk E, Rzeszotarska E, Walczyk M, et al. Variety of endosomal TLRs and Interferons (IFN-\u03b1, IFN-\u03b2, IFN-\u03b3) expression profiles in patients with SLE, Ssc and MCTD. Clin Exp Immunol. 2021;204:49\u201363.","journal-title":"Clin Exp Immunol"},{"key":"717_CR107","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2016.00578","volume":"7","author":"S Peng","year":"2016","unstructured":"Peng S, Li C, Wang X, Liu X, Han C, Jin T, et al. Increased Toll-Like receptors activity and TLR ligands in patients with autoimmune thyroid diseases. Front Immunol. 2016;7:578.","journal-title":"Front Immunol"},{"key":"717_CR108","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2119\/molmed.2014.00014","volume":"20","author":"DS Pisetsky","year":"2014","unstructured":"Pisetsky DS. The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo. Mol Med. 2014;20:158\u201363.","journal-title":"Mol Med"},{"key":"717_CR109","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.1124978","volume":"312","author":"P Pisitkun","year":"2006","unstructured":"Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006;312:1669\u201372.","journal-title":"Science"},{"key":"717_CR110","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/art.21398","volume":"52","author":"K Popovic","year":"2005","unstructured":"Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthr Rheum. 2005;52:3639\u201345.","journal-title":"Arthr Rheum"},{"key":"717_CR111","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.11028","volume":"48","author":"R Pullerits","year":"2003","unstructured":"Pullerits R, Jonsson I-M, Verdrengh M, Bokarewa M, Andersson U, Erlandsson-Harris H, et al. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthr Rheum. 2003;48:1693\u2013700.","journal-title":"Arthr Rheum"},{"key":"717_CR112","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1002\/art.20678","volume":"50","author":"TRDJ Radstake","year":"2004","unstructured":"Radstake TRDJ, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PLCM, Barrera P, et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthr Rheum. 2004;50:3856\u201365.","journal-title":"Arthr Rheum"},{"key":"717_CR113","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.4049\/jimmunol.170.7.3890","volume":"170","author":"B Rendon-Mitchell","year":"2003","unstructured":"Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol. 2003;170:3890\u20137.","journal-title":"J Immunol"},{"key":"717_CR114","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/ard.2007.086421","volume":"68","author":"MF Roelofs","year":"2009","unstructured":"Roelofs MF, Wenink MH, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, et al. Type I interferons might form the link between Toll-like receptor (TLR) 3\/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis. 2009;68:1486\u201393.","journal-title":"Ann Rheum Dis"},{"key":"717_CR115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2353\/ajpath.2007.060657","volume":"170","author":"SM Sacre","year":"2007","unstructured":"Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, Giddins G, et al. The Toll-like receptor adaptor proteins MyD88 and Mal\/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol. 2007;170:518\u201325.","journal-title":"Am J Pathol"},{"key":"717_CR116","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13075-020-2097-2","volume":"22","author":"S Samarpita","year":"2020","unstructured":"Samarpita S, Kim JY, Rasool MK, Kim KS. Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug. Arthr Res Ther. 2020;22:16.","journal-title":"Arthr Res Ther"},{"key":"717_CR117","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0040-2016","author":"T Satoh","year":"2016","unstructured":"Satoh T, Akira S. Toll-like receptor signaling and its inducible proteins. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0040-2016.","journal-title":"Microbiol Spectr"},{"key":"717_CR118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191\u20135.","journal-title":"Nature"},{"key":"717_CR119","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2119\/molmed.2010.00264","volume":"17","author":"H Schierbeck","year":"2011","unstructured":"Schierbeck H, Lundb\u00e4ck P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U, et al. Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mol Med. 2011;17:1039\u201344.","journal-title":"Mol Med"},{"key":"717_CR120","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3899\/jrheum.120987","volume":"40","author":"H Schierbeck","year":"2013","unstructured":"Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius \u00c5, et al. HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration. J Rheumatol. 2013;40:1604\u201313.","journal-title":"J Rheumatol"},{"key":"717_CR121","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0002-9440(10)63918-1","volume":"162","author":"R Seibl","year":"2003","unstructured":"Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003;162:1221\u20137.","journal-title":"Am J Pathol"},{"key":"717_CR122","volume":"2012","author":"Y Shi","year":"2012","unstructured":"Shi Y, Sandoghchian Shotorbani S, Su Z, Liu Y, Tong J, Zheng D, et al. Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis. Clin Dev Immunol. 2012;2012: 295081.","journal-title":"Clin Dev Immunol"},{"key":"717_CR123","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1073\/pnas.0603912103","volume":"103","author":"S Subramanian","year":"2006","unstructured":"Subramanian S, Tus K, Li Q-Z, Wang A, Tian X-H, Zhou J, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A. 2006;103:9970\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"717_CR124","volume":"4","author":"F Tamirou","year":"2018","unstructured":"Tamirou F, Arnaud L, Talarico R, Scir\u00e8 CA, Alexander T, Amoura Z, et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4: e000793.","journal-title":"RMD Open"},{"key":"717_CR125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2119\/molmed.2014.00063","volume":"20","author":"D Tang","year":"2014","unstructured":"Tang D, Kang R, Van Houten B, Zeh HJ, Billiar TR, Lotze MT. High mobility group box 1 (HMGB1) phenotypic role revealed with stress. Mol Med. 2014;20:359\u201362.","journal-title":"Mol Med"},{"key":"717_CR126","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","volume":"48","author":"N Taniguchi","year":"2003","unstructured":"Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthr Rheum. 2003;48:971\u201381.","journal-title":"Arthr Rheum"},{"key":"717_CR127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0968-0004(01)01801-1","volume":"26","author":"JO Thomas","year":"2001","unstructured":"Thomas JO, Travers AA. HMG1 and 2, and related \u2018architectural\u2019 DNA-binding proteins. Trends Biochem Sci. 2001;26:167\u201374.","journal-title":"Trends Biochem Sci"},{"key":"717_CR128","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri1396","volume":"4","author":"RJ Ulevitch","year":"2004","unstructured":"Ulevitch RJ. Therapeutics targeting the innate immune system. Nat Rev Immunol. 2004;4:512\u201320.","journal-title":"Nat Rev Immunol"},{"key":"717_CR129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1189\/jlb.2RI1115-531R","volume":"100","author":"MO Ullah","year":"2016","unstructured":"Ullah MO, Sweet MJ, Mansell A, Kellie S, Kobe B. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. J Leukoc Biol. 2016;100:27\u201345.","journal-title":"J Leukoc Biol"},{"key":"717_CR130","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, F\u00fcrnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med. 2008;205:3007\u201318.","journal-title":"J Exp Med"},{"key":"717_CR131","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1538-7836.2006.02033.x","volume":"4","author":"M Van de Wouwer","year":"2006","unstructured":"Van de Wouwer M, Plaisance S, De Vriese A, Waelkens E, Collen D, Persson J, et al. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost. 2006;4:1813\u201324.","journal-title":"J Thromb Haemost"},{"key":"717_CR132","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.phrs.2016.06.031","volume":"111","author":"E Venereau","year":"2016","unstructured":"Venereau E, De Leo F, Mezzapelle R, Careccia G, Musco G, Bianchi ME. HMGB1 as biomarker and drug target. Pharmacol Res. 2016;111:534\u201344.","journal-title":"Pharmacol Res"},{"key":"717_CR133","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248\u201351.","journal-title":"Science"},{"key":"717_CR134","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/dna.2018.4592","volume":"38","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang L, Gong Z. Regulation of acetylation in high mobility group protein B1 cytosol translocation. DNA Cell Biol. 2019;38:491\u20139.","journal-title":"DNA Cell Biol"},{"key":"717_CR135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/nar\/17.3.1197","volume":"17","author":"L Wen","year":"1989","unstructured":"Wen L, Huang JK, Johnson BH, Reeck GR. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res. 1989;17:1197\u2013214.","journal-title":"Nucleic Acids Res"},{"key":"717_CR136","doi-asserted-by":"crossref","first-page":"1093208","DOI":"10.3389\/fimmu.2023.1093208","volume":"14","author":"L Wen","year":"2023","unstructured":"Wen L, Zhang B, Wu X, Liu R, Fan H, Han L, et al. Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus. Front Immunol. 2023;14:1093208.","journal-title":"Front Immunol"},{"key":"717_CR137","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13075-015-0856-2","volume":"17","author":"L Wirestam","year":"2015","unstructured":"Wirestam L, Schierbeck H, Skogh T, Gunnarsson I, Ottosson L, Erlandsson-Harris H, et al. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus. Arthr Res Ther. 2015;17:338.","journal-title":"Arthr Res Ther"},{"key":"717_CR138","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1084\/jem.20070285","volume":"204","author":"H-J Wu","year":"2007","unstructured":"Wu H-J, Sawaya H, Binstadt B, Brickelmaier M, Blasius A, Gorelik L, et al. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med. 2007;204:1911\u201322.","journal-title":"J Exp Med"},{"key":"717_CR139","doi-asserted-by":"crossref","first-page":"1943918","DOI":"10.1155\/2016\/1943918","volume":"2016","author":"H Wu","year":"2016","unstructured":"Wu H, Li R, Wei Z-H, Zhang X-L, Chen J-Z, Dai Q, et al. Diabetes-induced oxidative stress in endothelial progenitor cells may be sustained by a positive feedback loop involving high mobility group box-1. Oxid Med Cell Longev. 2016;2016:1943918.","journal-title":"Oxid Med Cell Longev"},{"key":"717_CR140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1119(03)00605-X","volume":"312","author":"Q Wu","year":"2003","unstructured":"Wu Q, Zhang W, Pwee K-H, Kumar PP. Cloning and characterization of rice HMGB1 gene. Gene. 2003;312:103\u20139.","journal-title":"Gene"},{"key":"717_CR141","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1002\/jcp.30125","volume":"236","author":"J Xue","year":"2021","unstructured":"Xue J, Suarez JS, Minaai M, Li S, Gaudino G, Pass HI, et al. HMGB1 as a therapeutic target in disease. J Cell Physiol. 2021;236:3406\u201319.","journal-title":"J Cell Physiol"},{"key":"717_CR142","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.20101354","volume":"209","author":"D Yang","year":"2012","unstructured":"Yang D, Postnikov YV, Li Y, Tewary P, de la Rosa G, Wei F, et al. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J Exp Med. 2012;209:157\u201371.","journal-title":"J Exp Med"},{"key":"717_CR143","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.4049\/jimmunol.178.4.2204","volume":"178","author":"A Yarilina","year":"2007","unstructured":"Yarilina A, DiCarlo E, Ivashkiv LB. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol. 2007;178:2204\u201311.","journal-title":"J Immunol"},{"key":"717_CR144","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2014.01.006","volume":"151","author":"NA Young","year":"2014","unstructured":"Young NA, Wu L-C, Burd CJ, Friedman AK, Kaffenberger BH, Rajaram MVS, et al. Estrogen modulation of endosome-associated toll-like receptor 8: an IFN\u03b1-independent mechanism of sex-bias in systemic lupus erythematosus. Clin Immunol. 2014;151:66\u201377.","journal-title":"Clin Immunol"},{"key":"717_CR145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clim.2016.12.005","volume":"176","author":"NA Young","year":"2017","unstructured":"Young NA, Valiente GR, Hampton JM, Wu L-C, Burd CJ, Willis WL, et al. Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus. Clin Immunol. 2017;176:12\u201322.","journal-title":"Clin Immunol"},{"key":"717_CR146","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0507323","volume":"83","author":"CK Zetterstr\u00f6m","year":"2008","unstructured":"Zetterstr\u00f6m CK, Jiang W, W\u00e4h\u00e4maa H, Ostberg T, Aveberger A-C, Schierbeck H, et al. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate. J Leukoc Biol. 2008;83:31\u20138.","journal-title":"J Leukoc Biol"},{"key":"717_CR147","first-page":"24","volume":"3","author":"S Zhang","year":"2009","unstructured":"Zhang S, Zhong J, Yang P, Gong F, Wang C-Y. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol. 2009;3:24\u201338.","journal-title":"Int J Clin Exp Pathol"},{"key":"717_CR148","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00125-020-05105-8","volume":"63","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen L, Wang F, Zou Y, Li J, Luo J, et al. Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability. Diabetologia. 2020;63:987\u20131001.","journal-title":"Diabetologia"},{"key":"717_CR149","volume":"94","author":"J Zhang","year":"2021","unstructured":"Zhang J, Li Q, Zou Y-R, Wu S-K, Lu X-H, Li G-S, et al. HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils. Int Immunopharmacol. 2021;94: 107433.","journal-title":"Int Immunopharmacol"},{"key":"717_CR150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7150\/ijms.66167","volume":"19","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu J, Mao C, Zhang S, Wang X, Dong L. SJMHE1 protects against excessive iodine-induced pyroptosis in human thyroid follicular epithelial cells through a toll-like receptor 2-dependent pathway. Int J Med Sci. 2022;19:631\u20139.","journal-title":"Int J Med Sci"},{"key":"717_CR151","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbadis.2014.04.030","volume":"1852","author":"G-N Zhao","year":"2015","unstructured":"Zhao G-N, Jiang D-S, Li H. Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. Biochim Biophys Acta. 2015;1852:365\u201378.","journal-title":"Biochim Biophys Acta"},{"key":"717_CR152","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar3384","volume":"13","author":"W Zhu","year":"2011","unstructured":"Zhu W, Meng L, Jiang C, He X, Hou W, Xu P, et al. Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts. Arthritis Res Ther. 2011;13:R103.","journal-title":"Arthritis Res Ther"},{"key":"717_CR153","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/annrheumdis-2012-202207","volume":"72","author":"M Zong","year":"2013","unstructured":"Zong M, Bruton JD, Grundtman C, Yang H, Li JH, Alexanderson H, et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann Rheum Dis. 2013;72:1390\u20139.","journal-title":"Ann Rheum Dis"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00717-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T09:24:52Z","timestamp":1730021092000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00717-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00717-3","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"28 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}